Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Nautilus Biotechnology Inc (NAUT)

Nautilus Biotechnology Inc (NAUT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Nautilus Biotechnology Co-founder and Chief Scientist Parag Mallick, Ph.D., Honored with the Academy for Radiology and Biomedical Imaging Research’s Distinguished Investigator Award

NAUT : 2.30 (+2.68%)
Nautilus Biotechnology to Participate in the Inaugural Guggenheim Healthcare Conference

NAUT : 2.30 (+2.68%)
Nautilus Biotechnology Reports Third Quarter 2024 Financial Results

NAUT : 2.30 (+2.68%)
Nautilus Biotechnology to Announce Third Quarter 2024 Financial Results on October 29, 2024

NAUT : 2.30 (+2.68%)
Nautilus Biotechnology Reports Second Quarter 2022 Financial Results

SEATTLE, Aug. 02, 2022 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single molecule proteome...

NAUT : 2.30 (+2.68%)
Nautilus Biotechnology to Announce Second Quarter 2022 Financial Results on August 2, 2022

SEATTLE, July 13, 2022 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein...

NAUT : 2.30 (+2.68%)
Nautilus Biotechnology Reports First Quarter 2022 Financial Results

SEATTLE, May 03, 2022 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single molecule proteome...

NAUT : 2.30 (+2.68%)
Nautilus Biotechnology to Announce First Quarter 2022 Financial Results on May 3, 2022

SEATTLE, April 07, 2022 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein...

NAUT : 2.30 (+2.68%)
Nautilus Biotechnology to Present at EuPA and AACR Meetings

• Co-founder and Chief Scientist Parag Mallick, Ph.D., to present lecture at Annual Congress of the European Proteomics Association (EuPA) • Associate...

NAUT : 2.30 (+2.68%)
Nautilus Biotechnology Appoints Karen Akinsanya, Ph.D., to Board of Directors

Schrödinger President of R&D, Therapeutics brings extensive leadership in commercializing breakthrough biotechnologies to company developing platform for...

NAUT : 2.30 (+2.68%)

Barchart Exclusives

Buy the Dip in This Dividend Aristocrat for a Strong 2025
McDonald's has faced challenges in 2024, including an E. coli outbreak, but is investing $100 million to recover and win back customers. With a strong brand, solid finances, and a clear growth strategy, the company's recent dip presents a rare chance to invest in a proven market leader with a long-term dividend growth streak. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar